Stock VENTRUS BIOSCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Ventrus Biosciences Inc Nasdaq

Equities

US9228221019

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Ventrus Biosciences Inc
05-08 Assembly Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-28 Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Ventrus Biosciences Inc

1d10ee465b5d8d2c8cfb09d.NitiLnr0EDgu101wEaB-TKX3VrtLE_Gul64Af7u7ib8.b0RWdhezdWlivXoHScwKO9_FB-0RSZf81dlmPoPw-sp9GydqFsdyd2qwGA~247a5e590fa7cede581e4ef7237664a8

Upcoming events on Ventrus Biosciences Inc

28/05/2024 Annual General Meeting
06/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
05/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Ventrus Biosciences Inc

08/05/2024 21:05 Q1 2024 Earnings Release
28/03/2024 20:05 Q4 2023 Earnings Release
11/02/2024 Reverse Split: 1 of 12
31/01/2024 16:00 Extraordinary Shareholders Meeting
12/11/2023 13:30 AASLD Liver Meeting
10/11/2023 17:00 AASLD Liver Meeting - Poster Number: 1474-C
08/11/2023 21:05 Q3 2023 Earnings Release
17/10/2023 13:30 Business Update Call
22/09/2023 03:00 International HBV Meeting
20/09/2023 09:15 International HBV Meeting
20/09/2023 07:30 International HBV Meeting
09/08/2023 21:05 Q2 2023 Earnings Release
14/07/2023 International Herpesvirus Workshop
24/06/2023 08:00 EASL International Liver Congress - Poster NO-186
24/06/2023 08:00 EASL International Liver Congress - Poster NO-168
24/06/2023 08:00 EASL International Liver Congress - Poster NO-195
24/06/2023 08:00 EASL International Liver Congress - Poster No-174
21/06/2023 08:00 European Association for the Study of the Liver Congress - Poster NO-114
20/06/2023 European Association for the Study of the Liver Congress
07/06/2023 21:00 Jefferies Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		16,0
14,8
7.82%		79,1
82,0
-3.54%		6,25
6,16
1.5%		0,00
0,00
- 		7,16
0,00
-
24,2

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-103
-104
0.93%		-64,8
-52,0
-24.5%		-91,1
-91,0
-0.09%		-94,1
-93,2
-1.02%		-64,6
-68,6
5.76%
-58,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-98,4
-98,6
0.21%		-62,2
-53,7
-15.75%		-132
-90,7
-45.9%		-93,1
-92,9
-0.15%		-61,2
-66,1
7.37%
-52,5

Net income
Million USD		Released
Forecast
Spread 		-97,6
-98,6
0.99%		-62,2
-53,7
-15.75%		-130
-90,8
-43.06%		-93,1
-92,9
-0.15%		-61,2
-66,1
7.32%
-52,5

EPS
USD		Released
Forecast
Spread 		-44,6
-44,9
0.67%		-21,0
-18,7
-12.47%		-36,0
-25,3
-42.52%		-23,0
-23,0
-0.26%		-13,4
-14,3
6.3%
-9,46

Announcement Date04/03/2025/02/2111/03/2222/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		7,16
0,00
- 		0,00
0,00
-
5,96


6,14


6,32

EBIT
Million USD		Released
Forecast
Spread 		-23,2
-21,0
-10.09%		-24,6
-23,8
-3.25%		-23,4
-26,1
10.34%		-23,0
-27,2
15.52%		-19,6
-17,8
-10.19%		-17,5
-15,5
-12.83%		-15,0
-13,0
-15.75%		-12,6
-16,5
23.93%		-10,7
-18,3
41.37%
-13,8


-15,9


-18,2

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-23,1
-21,0
-10.06%		-24,5
-23,8
-2.92%		-23,1
-26,1
11.32%		-22,4
-27,2
17.67%		-19,0
-17,4
-8.75%		-16,9
-15,2
-11.34%		-14,4
-12,3
-17.24%		-10,9
-15,8
30.83%		-9,08
-17,6
48.43%
-12,3


-14,4


-16,7

Net income
Million USD		Released
Forecast
Spread 		-23,1
-21,0
-10.06%		-24,5
-23,8
-2.92%		-23,1
-26,1
11.32%		-22,4
-27,2
17.67%		-19,0
-17,4
-8.75%		-16,9
-15,2
-11.34%		-14,4
-12,3
-17.24%		-11,0
-15,8
30.62%		-9,08
-17,6
48.43%
-12,3


-14,4


-16,7

EPS
USD		Released
Forecast
Spread 		-5,76
-5,70
-1.05%		-6,12
-5,88
-4.08%		-5,76
-6,48
11.11%		-5,52
-6,72
17.86%		-4,44
-4,26
-4.23%		-3,84
-3,48
-10.34%		-3,24
-2,76
-17.39%		-1,74
-2,88
39.58%		-1,66
-3,23
48.61%
-2,23


-2,58


-2,98

Announcement Date12/05/2209/08/2208/11/2222/03/2304/05/2309/08/2308/11/2328/03/2408/05/24---

Upcoming sector events for Ventrus Biosciences Inc

24/07/2024 INDIVIOR PLC: Q2 2024 Earnings Release (Projected)
28/07/2024 KISSEI PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
29/07/2024 SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.: Q2 2024 Earnings Release (Projected)
31/07/2024 KYOWA KIRIN CO. LTD.: Q2 2024 Earnings Release (Projected)
01/08/2024 06:00 MERCK KGAA: Q2 2024 Earnings Release
05/08/2024 SUPERNUS PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
06/08/2024 BETTA PHARMACEUTICALS CO., LTD.: Q2 2024 Earnings Release (Projected)
12/08/2024 YUHAN CORPORATION: Q2 2024 Earnings Release (Projected)
12/08/2024 HK INNO.N CORPORATION: Q2 2024 Earnings Release (Projected)
12/08/2024 CALLIDITAS THERAPEUTICS AB: Q2 2024 Earnings Release
More events

Past sector events for Ventrus Biosciences Inc

Today 06:00 MERCK KGAA: Q1 2024 Earnings Release
12/05/2024 MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected)
09/05/2024 OSCOTEC INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release
08/05/2024 21:05 SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
06/05/2024 KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
06/05/2024 KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release
06/05/2024 CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release
29/04/2024 YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release
29/04/2024 HK INNO.N CORPORATION: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ASMB Stock
  4. Stock
  5. Calendar Ventrus Biosciences Inc